Medical Communications

New research published in The Lancet has revealed that type 1 diabetes cannot be understood as a “disease of the …

Novartis has released new data for Consentyx (secukinumab) which it claims make the IL-17A inhibitor “the first biologic to show …

Vir Biotechnology, a developer of treatments that induce protective and therapeutics immune responses, has hired a CSO with a strong …

Dr Chris Barber, CEO of not-for-profit organisation and educational charity Lhasa Limited, discusses new innovations and ideas that are set …

The Department of Health and Human Services’ Office of Inspector General (OIG) has rescinded authorisation for one of the US’ …

A new report from RSA Group has revealed that European biotech companies are “significantly outperforming” their US counterparts in terms …

Pharmafocus December edition is available to read online now!

PrimeVigilance is pleased to announce their collaboration with the International Society of Pharmacovigilance (ISoP) on the upcoming seminar, organised by …

Recipharm, a leading contract development and manufacturing organisation (CDMO) has equipped three more of its facilities with serialisation capabilities in …

The Veeva European Commercial & Medical Summit will begin tomorrow, seeing more than 800 industry leaders convene at the Marriot …

Increasingly collaborative efforts have seen the threat of HIV recede and brought hope to demographics and communities most vulnerable to …

It’s been a rocky year for AstraZeneca, it has scored some major successes yet its year has been marred by …

The UK government’s Autumn Budget struck a gloomy note for the economy, with figures pointing towards low productivity and the …

As Friday comes round again, this week saw some of the biggest news of the year: Amsterdam is the new …

Researchers, based in the US, have conducted a large-scale collection of publicly available data and found that significant differences can …